Table 2.
Women | Men | ||||||
---|---|---|---|---|---|---|---|
Non-obese | Obese | Non-obese | Obese | P 2-way-ANOVA | |||
Patients | n = 22 | n = 44 | n = 20 | n = 23 | Obesity | Gender | Inter- Action |
Glucose (mg/dL) | 94.0 ± 8.7 | 101.6 ± 2.1 | 97.8 ± 4.7 | 98.3 ± 8.7 | 0.105 | 0.660 | 0.836 |
Insulin (μU/mL) | 8.6 ± 1.4 | 18.2 ± 0.7 | 5.9 ± 1.7 | 24.7 ± 5.6 | <0.001 | 0.456 | 0.063 |
HbA1C (%) | 5.2 ± 0.1 | 10.6 ± 2.9 | 5.8 ± 0.7 | 11.6 ± 4.7 | 0.053 | 0.549 | 0.418 |
C-Peptide (ng/mL) | 2.0± 0.4 | 4.3 ± 0.2 | 2.2 ± 0.4 | 5.8 ± 0.8 | <0.001 | 0.286 | 0.459 |
HOMA β (%) | 94.2 ± 16.1 | 134.2 ± 9.1 | 69.3 ± 10.2 | 175.4 ± 20.7 | <0.001 | 0.590 | 0.031 |
HOMA-S (%) | 88.7 ±12.3 | 41.8 ± 5.3 | 125.5 ± 11.6 | 32.4 ± 7.7 | <0.001 | 0.133 | 0.012 |
HOMA-IR (AU) | 1.1 ± 0.3 | 2.4 ± 0.2 | 0.8 ± 0.1 | 3.1 ± 0.6 | <0.001 | 0.578 | 0.166 |
Triglycerides (mg/dL) | 77.6 ± 16.8 | 129.0 ± 34.4 | 108.8 ± 8.4 | 163 ± 17.5 | 0.212 | 0.449 | 0.966 |
Cholesterol (mg/dL) | 123.0 ± 13.6 | 154.7 ± 6.7 | 162.5 ± 31.0 | 158.4 ± 11.3 | 0.601 | 0.311 | 0.442 |
LDL-C (mg/dL) | 63.1 ± 8.3 | 86.0 ± 4.4 | 94.3 ± 19.6 | 95 ± 7.6 | 0.526 | 0.526 | 0.54 |
HDL-C (mg/dL) | 44.4 ± 12.8 | 42.8 ± 2.2 | 55.7 ± 12.2 | 34.6 ± 3.7 | 0.092 | 0.816 | 0.147 |
Leptin (ng/mL) | 19.9 ± 8 | 71.7 ± 7.1 | 6.8 ± 0.2 | 28.1 ± 6.8 | <0.005 | 0.062 | 0.134 |